{
  "meta": {
    "id": "test16",
    "title": "Asthma (Part 2)",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Aspirin-sensitive asthma is associated with an old male k/c/o ischemic heart disease, recently started on antiplatelet agents, and presented with breathlessness and wheezing. On chest auscultation, he had rhonchi all over. There were no features of heart failure. Which of the following could be found on his general examination?",
      "options": [
        {
          "label": "A",
          "text": "Obesity",
          "correct": false
        },
        {
          "label": "B",
          "text": "Urticaria",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nasal polyp",
          "correct": true
        },
        {
          "label": "D",
          "text": "Extrinsic asthma",
          "correct": false
        }
      ],
      "correct_answer": "C. Nasal polyp",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Nasal polyp A subset of patients (5\u201310%) present in adulthood with difficult-to-control asthma and type 2 inflammation with eosinophilia, sinusitis, nasal polyposis, and severe asthma exacerbations that are precipitated by ingesting inhibitors of cyclooxygenase, with aspirin being the most prominent of such inhibitors. Such patients, classified as having aspirin-exacerbated respiratory disease, overproduce leukotrienes in response to the inhibition of cyclooxygenase-1, probably secondary to inhibition of PGE2.</p>\n<p><strong>Highyeild:</strong></p><p>History of IHD and use of anti-platelet drug - Aspirin Breathlessness and wheezing with rhonchi are the possible asthma features Diagnosis can be Aspirin- sensitive asthma, nasal polyps are seen in aspirin-sensitive asthma</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect Options: - Option: A. Obesity is not related to aspirin-sensitive asthma Option: B. Urticaria is not seen in aspirin-sensitive asthma, it is mostly seen in allergies of the skin and other commonly related problems Option: D. Aspirin-sensitive asthma is not of the extrinsic type</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1c7a4a96",
      "audio": ""
    },
    {
      "text": "Which of the following drug is used in refractory asthma? Which of the following monoclonal antibodies would be used for a patient presenting with an exacerbation of asthma and not responding to bronchodilators and systemic steroids?",
      "options": [
        {
          "label": "A",
          "text": "Omalizumab",
          "correct": true
        },
        {
          "label": "B",
          "text": "Infliximab",
          "correct": false
        },
        {
          "label": "C",
          "text": "Alemtuzumab",
          "correct": false
        },
        {
          "label": "D",
          "text": "Eculizumab",
          "correct": false
        }
      ],
      "correct_answer": "A. Omalizumab",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Omalizumab Acute Severe Asthma: Treatment:-</p>\n<p><strong>Highyeild:</strong></p><p>Best Initial Treatment A high concentration of oxygen. Short-acting inhaled Beta2-agonists. (Albuterol ), Pirbuterol, Levelbuterol Bolus Dose Of Steroid B. If the above treatment does not work then do the following: Slow infusion of aminophylline. Magnesium sulfate is given intravenously. These patients may benefit from an anaesthetic, such as halothane if they have not responded to conventional bronchodilators. Sedatives should never be given as they may depress ventilation. Antibiotics should not be used routinely unless there are signs of pneumonia. In severe acute asthma sedatives and montelukast are not given.</p>\n<p><strong>Extraedge:</strong></p><p>Recent Advance: New Drugs:- Anti-IgE monoclonal antibody Omalizumab is a new drug Q be of use in highly selected patients with persistent allergic asthma (PQ) It is an IgE blocker . MgSO4 is used in severe asthma. Bambuterol is a very long-acting beta-adrenoceptor agonist (LABA) used in the treatment of asthma; it also is a prodrug of terbutaline. Corticosteroid resistance asthma. It is defined as failure to respond to a high dose of oral prednisolone (40 mg OD for 2 weeks). Cox -2 inhibitors are safe for asthma Cigarette smoking \u2013 There is evidence that smoking interferes with the anti-inflammatory action of corticosteroids Anticholinergics like ipratropium are less effective in asthma. They are more effective in COPD All asthma patients should be given influenza and pneumococcal vaccination</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2e1cc20d",
      "audio": ""
    },
    {
      "text": "All of the following are true about Kartagener's syndrome, Except:",
      "options": [
        {
          "label": "A",
          "text": "Dextrocardia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Infertility",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mental retardation",
          "correct": true
        },
        {
          "label": "D",
          "text": "Bronchiectasis",
          "correct": false
        }
      ],
      "correct_answer": "C. Mental retardation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Mental retardation Kartagener \u2018s syndrome includes dextrocardia, infertility, and bronchiectasis as its main clinical features. The symptoms occur due to the immotile cilia formation and mental retardation is not a feature seen Kartagener's syndrome is a rare, autosomal recessive genetic ciliary disorder comprising the triad of situs inversus, chronic sinusitis, and bronchiectasis . The basic problem lies in the defective movement of cilia, leading to recurrent chest infections, ear/nose/throat symptoms, and infertility.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f4a37b7f",
      "audio": ""
    },
    {
      "text": "A 30-year-old man has been experiencing recurrent attacks of asthma, for which he is on treatment. Recently, he has also started experiencing nasal blockage and nasal discharge, for which he visited an ENT specialist. He was found to have Bilateral Nasal polyposis. As his Doctor, which of the following drugs will you tell the patient he is sensitive to and hence, should not be prescribed to him?",
      "options": [
        {
          "label": "A",
          "text": "Co-amoxiclav",
          "correct": false
        },
        {
          "label": "B",
          "text": "Aspirin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Cotrimoxazole",
          "correct": false
        },
        {
          "label": "D",
          "text": "Proton pump inhibitors",
          "correct": false
        }
      ],
      "correct_answer": "B. Aspirin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Aspirin This is a case of Samter\u2019s triad or AERD (Aspirin exacerbated respiratory disease), characterised by Bronchial asthma, Nasal polyposis and Aspirin sensitivity . Such patients overproduce leukotrienes in response to the inhibition of COX-1, probably secondary to the inhibition of PGE2. Treatment Option:s include ICS, leukotriene modifiers, Aspirin desensitisation and biologicals against IL 4 and IL 5.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option:s A, C, and D are not associated with asthma exacerbations.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "80616ffd",
      "audio": ""
    },
    {
      "text": "A patient presented to the emergency room with acute onset of shortness of breath, which is present at rest. He is severely dyspneic and is unable to complete sentences. On examination, his pulse rate is 120 bpm, respiratory rate is 35/min, and Spo2 under room air is 93%. He is afebrile, there is no cyanosis or clubbing. On chest examination, he has Bilateral polyphonic loud wheeze. Which of the following will not be used as a treatment Option: for him?",
      "options": [
        {
          "label": "A",
          "text": "Oxygen inhalation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Subcutaneous bronchodilators",
          "correct": false
        },
        {
          "label": "C",
          "text": "Corticosteroids",
          "correct": false
        },
        {
          "label": "D",
          "text": "Theophylline",
          "correct": true
        }
      ],
      "correct_answer": "D. Theophylline",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Theophylline The clinical scenario presented is of an Acute exacerbation of bronchial asthma, which can be a life-threatening emergency if not treated timely. Theophylline or Aminophylline are not recommended for the treatment of acute asthma exacerbations according to the latest guidelines. They have a very narrow therapeutic range and hence, require close monitoring. Oxygen inhalation, Subcutaneous bronchodilators and corticosteroids play a vital role in the management of asthma exacerbations.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7027d68d",
      "audio": ""
    },
    {
      "text": "Which of the following drugs is not used in the management of bronchial asthma?",
      "options": [
        {
          "label": "A",
          "text": "Mepolizumab",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dupilumab",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ustekinumab",
          "correct": true
        },
        {
          "label": "D",
          "text": "Lebrikizumab",
          "correct": false
        }
      ],
      "correct_answer": "C. Ustekinumab",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Ustekinumab Ustekinumab is a monoclonal antibody targeting both IL-12 and IL-23 used for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect Options: - Option: A. Mepolizumab is a humanized monoclonal antibody targeting IL-5 . It can be used for the treatment of severe eosinophilic asthma, eosinophilic granulomatosis, and hypereosinophilic syndrome. Option: B. Dupilumab targets IL-4 and IL-13, it is approved for use in Atopic dermatitis, Asthma, Chronic rhinosinusitis with nasal polyposis and Eosinophilic esophagitis. Option: D. Lebrikizumab is an IL-13 blocker which is used for the treatment of asthma that cannot be adequately controlled with ICS.</p>\n<p><strong>Extraedge:</strong></p><p>Dupilumab reduces exacerbations by \u226550%, decreases symptoms, and may produce more of an effect on FEV1 than anti\u2013IL-5 drugs. It gradually reduces FeNO and IgE levels. Paradoxically, circulating eosinophil counts may initially temporarily increase. Most effects are seen by 3\u20136 months of therapy.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b190b490",
      "audio": ""
    },
    {
      "text": "A patient with bronchial asthma was subjected to a sputum examination. Which of the following findings in the sputum does not support the diagnosis of asthma?",
      "options": [
        {
          "label": "A",
          "text": "Image A",
          "correct": false
        },
        {
          "label": "B",
          "text": "Image B",
          "correct": true
        },
        {
          "label": "C",
          "text": "Image C",
          "correct": false
        },
        {
          "label": "D",
          "text": "Image D",
          "correct": false
        }
      ],
      "correct_answer": "B. Image B",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1683855702381-QTDM142008IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Image B Image B. Depicts the ping pong ball appearance of Pneumocystis jirovecii on Gomori Methenamine stain. Image A. Shows Curshmann spirals . They are spiral-shaped mucus plug s from subepithelial mucous gland ducts of the bronchi Image C. Shows Creola bodies which are ciliated columnar cells sloughed from the bronchial mucosa of a patient with asthma. Image D. Shows Charcot\u2013Leyden crystals which are microscopic crystals composed of eosinophil protein galectin-10 found in people who have allergic diseases such as asthma or parasitic infections such as parasitic pneumonia or ascariasis.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c0a40a17",
      "audio": ""
    },
    {
      "text": "Bronchial asthma is characterised by episodic reversible airway obstruction and airway hyper-responsiveness usually accompanied by airway inflammation. Which of the following supports the same?",
      "options": [
        {
          "label": "A",
          "text": "10% increase in FEV1 post bronchodilator",
          "correct": false
        },
        {
          "label": "B",
          "text": "Diurnal peak flow variability of >12 %",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increase in FEV1 by 350 ml post bronchodilator",
          "correct": true
        },
        {
          "label": "D",
          "text": "Drop in FEV1 by 15% on the Methacholine challenge test",
          "correct": false
        }
      ],
      "correct_answer": "C. Increase in FEV1 by 350 ml post bronchodilator",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Increase in FEV1 by 350 ml post bronchodilator Increase in FEV1 by 350 ml post Bronchodilator\\\\Reversibility is defined as a \u226512% increase in the FEV1 and an absolute increase of \u2265200 mL at least 15 min after administration of a \u03b22-agonist or after several weeks of corticosteroid therapy. Diurnal peak flow variability of >20% has also been proposed as an indicator of reversible airway disease, but it is less reliable due to difficulties with quality control and variability of home assessments. Lung volumes and diffusing capacity should be normal in uncomplicated asthma.</p>\n<p><strong>Highyeild:</strong></p><p>An absolute increase of \u2265200 mL in FEV1 at least 15 min after administration of a \u03b22-agonist or after several weeks of corticosteroid therapy.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect Options: - Option: A. Reversibility is defined as a \u226512% increase in the FEV1 at least 15 min after administration of a \u03b22-agonist or after several weeks of corticosteroid therapy. Option: B. Diurnal peak flow variability of >20% has also been proposed as an indicator of reversible airway disease. Option: D. Methacholine, a cholinergic agonist, is used for provocative testing. A provocative dose producing a 20% drop in FEV1 (PD20) is calculated, with a value \u2264400 \u03bcg indicative of airway reactivity.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "890726b4",
      "audio": ""
    },
    {
      "text": "Which of the following are predictors for mortality in a patient with asthma? (i) History of ICU admission (ii) Illicit drug use (iii) High socioeconomic status (iv) Depression (v) History of intubation for asthma Select the correct answer from the given below code:",
      "options": [
        {
          "label": "A",
          "text": "(i), (ii), (iii)",
          "correct": false
        },
        {
          "label": "B",
          "text": "(i), (ii), (iv), (v)",
          "correct": true
        },
        {
          "label": "C",
          "text": "(i),(v)",
          "correct": false
        },
        {
          "label": "D",
          "text": "(i), (iii), (v)",
          "correct": false
        }
      ],
      "correct_answer": "B. (i), (ii), (iv), (v)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>(i), (ii), (iv), (v) Patients at greater risk for asthma mortality- History of intensive care unit admission for asthma History of intubation for asthma Illicit drug use Depression New Diagnosis \u22652 emergency unit visits in the past 6 months Severe psychosocial problems Lower socioeconomic status On daily prednisone prior to admission</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3c79f27f",
      "audio": ""
    },
    {
      "text": "Which of the following are signs of imminent respiratory failure in a patient with acute severe asthma? (I) Altered sensorium (II) Silent chest (III) Loud wheezing (IV) Paradoxical respiration (V) Decreased Pco2 Select the correct answer from the given below code:",
      "options": [
        {
          "label": "A",
          "text": "(i), (ii), (iii)",
          "correct": false
        },
        {
          "label": "B",
          "text": "(i), (ii), (iv), (v)",
          "correct": false
        },
        {
          "label": "C",
          "text": "(i),(v)",
          "correct": false
        },
        {
          "label": "D",
          "text": "(i), (ii), (iv)",
          "correct": true
        }
      ],
      "correct_answer": "D. (i), (ii), (iv)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>(i), (ii), (iv) Signs of imminent respiratory failure in a patient with acute severe asthma: Breathlessness at rest or while mute Drowsy or confused RR >30/min, can decrease due to respiratory muscle fatigue Unable to recline Silent chest Paradoxical thoracoabdominal movement Bradycardia Absent pulsus paradoxus FEV1 < 25% Pao2 <60, possible cyanosis PCO2 > 42mm Hg Sao2 <90%</p>\n<p><strong>Highyeild:</strong></p><p>Signs of imminent respiratory failure in a patient with acute severe asthma: Breathlessness at rest or while mute Drowsy or confused RR >30/min, can decrease due to respiratory muscle fatigue Unable to recline Silent chest Paradoxical thoracoabdominal movement Bradycardia Absent pulsus paradoxus FEV1 < 25% Pao2 <60, possible cyanosis PCO2 > 42mm Hg Sao2 <90%</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "207e960f",
      "audio": ""
    },
    {
      "text": "Which of the following are triggers for airway narrowing in a patient with asthma?",
      "options": [
        {
          "label": "A",
          "text": "Exercise",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pregnancy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Viral infections",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>All of the above Triggers of Airway Narrowing: Allergens Irritants Viral infections Exercise and cold, dry air Air pollution Drugs Occupational exposures Hormonal changes Pregnancy</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5fd39ace",
      "audio": ""
    }
  ]
}